Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption

Microscopy Research and Technique

Volumn 61, Issue 6, 2003, Pages 483-495

  Sasaki, Takahisa ^a  

^a SHOWA UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

Author keywords

Cathepsin K; Odontoclasts; Osteoprotegerin; Receptor activator of NFKB ligand; Vacuolar type H+ ATPase

Indexed keywords

AMINO ACIDS; BONE; CELL CULTURE; CELL DEATH; MAMMALS; MICROSTRUCTURE; OSTEOBLASTS; PHOSPHATASES;

CATHEPSIN K; H +-ATPASE; MINERALIZED TISSUE; ODONTOCLAST; OSTEOPROTEGERIN; PERIODONTAL LIGAMENT; RECEPTOR ACTIVATOR; RECEPTOR ACTIVATOR OF NFKB LIGAND; TARTRATE-RESISTANT ACID PHOSPHATASE; VACUOLAR-TYPE H+-ATPASE;

LIGANDS;

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ADENOSINE TRIPHOSPHATASE; BAFILOMYCIN A1; CATHEPSIN K; GELATINASE B; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL ULTRASTRUCTURE; DENTIN; MOUSE; NONHUMAN; ODONTOCLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TOOTH;

LACUNA;

EID: 0037766297     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jemt.10370     Document Type: Article

References (78)

1. Abu-Amer Y, Ross FP, Schlesinger P, Tondravi MM, Teitelbaum SL. 1997. Substrate recognition by osteoclast precursors induces c-src/microtubule association. J Cell Biol 137:247-258.
2. Akatsu T, Murakami T, Nishikawa M, Ono K, Shinomiya N, Tsuda E, Mochizuki S, Yamaguchi K, Kinosaki M, Higashio K, Yamamoto M, Motoyoshi K, Nagata N. 1998. Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast. Biochem Biophys Res Commun 250:229-234.
3. Bateman TA, Dunstan CR, Ferguson VL, Lacey DL, Ayers RA, Simske SJ. 2000. Osteoprotegerin mitigates tail suspension-induced osteopenia. Bone 26:443-449.
4. Bossard MJ, Tomaszek TA, Thompson SK, Amegadzie BY, Hanning CR, Jones C, Kurdyla JT, McNulty DE, Darke FH, Gowen M, Levy MA. 1996. Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification. J Biol Chem 271:12517-12524.
5. Bowman EJ, Siebers A, Altendorf K. 1988. Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci USA 85:7972-7976.
6. Boyde A, Ali NN, Jones SJ. 1984. Resorption of dentine by isolated osteoclasts in vitro. Br Dent J 156:216-220.
7. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS. 1998. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12:1260-1268.
8. Debari K, Sasaki T, Udagawa N, Rifkin BR. 1995. An ultrastructural evaluation of the effects of cysteine-proteinase inhibitors on osteoclastic resorptive functions. Calcif Tissue Int 56:566-570.
9. Delaisse JM, Vaes G. 1992. Mechanism of mineral solubilization and matrix degradation in osteoclastic bone resorption. In: Rifkin BR, Gay CV, editors. Biology and physiology of the osteoclasts. Boca Raton: CRC Press. p 289-314.
10. Dougall WC, Glaccum M, Charrier K, Rohrback K, Brasel K, De Smedt T, Daro E, Smith J, Tometsko ME, Maliszewski CR, Armstrong A, Shen V, Bain S, Cosman D, Anderson D, Morrissey PJ, Peschon JJ, Schuh J. 1999. Rank is essential for osteoclast and lymph node development. Genes Dev 13:2412-2424.
11. Drake FH, Doods RA, James IE, Conner JR, Debouck C, Richardson S, Lee-Rykaczewski E, Coleman L, Rieman D, Barthlow R, Hastings G, Gowen M. 1996. Cathepsin K, but not B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem 271:12511-12516.
12. Everts V, Delaisse JM, Korper W, Niehof A, Vaes G, Beertsen W. 1992. Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases. J Cell Physiol 150:221-231.
13. Everts V, Delaisse JM, Korper W, Beertsen W. 1998. Cysteine proteinases and matrix metalloproteinases play distinct roles in the subosteoclastic resorption zone. J Bone Miner Res 13:1420-1430.
14. Fuller K, Wong B, Fox S, Choi Y, Chambers TJ. 1998. TRANCE is necessary and sufficient for osteoclast-mediated activation of bone resorption in osteoclasts. J Exp Med 188:997-1001.
15. Gowen M, Lazner F, Dodds R, Kapadia R, Field J, Tavaria M, Bertoncello I, Drake F, Zavarselk S, Tellis I, Hertzog P, Debouck C, Kola I. 1999. Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. J Bone Miner Res 14:1654-1663.
16. +-ATPase contains filamentous actin binding site. J Biol Chem 275:32331-32337.
17. Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, Wang L, Xia XZ, Elliott R, Chiu L, Black T, Scully S, Capparelli C, Morony S, Shimamoto G, Bass MB, Boyle WJ. 1999. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 96:3540-3545.
18. Inui T, Ishibashi O, Inaoka T, Origane Y, Kumegawa M, Kokubo T, Yamamura T. 1997. Cathepsin K antisense oligodeoxynucleotide inhibits osteoclastic bone resorption. J Biol Chem 272:8109-8112.
19. Jimi E, Akiyama S, Tsurukai T, Okahashi N, Kobayashi K, Udagawa N, Nishimura T, Takahashi N, Suda T. 1999. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J Immunol 163:434-442.
20. Jones SJ, Boyde A, Ali NN. 1984. The resorption of biological and non-biological substrates by cultured avian and mammalian osteoclasts. Anat Embryol 170:247-256.
21. Kamiya T, Kobayashi Y, Kanaoka K, Nakashima T, Kato Y, Mizuno A, Sakai H. 1998. Fluorescence microscopic demonstration of cathepsin K activity as the major lysosomal cysteine proteinase in osteoclasts. J Biochem 123:752-759.
22. Kartsogiannis V, Zhou H, Horwood NJ, Thomas RJ, Hards DK, Quinn JMW, Niforas P, Ng KW, Martin TJ, Gillespie MT. 1999. Localization of RANKL (receptor activator of NFKB ligand) mRNA and protein in skeletal and extraskeletal tissues. Bone 25:525-534.
23. Kong YY, Yoshida H, Sarosi HL, Tan E, Timms C, Capparelli S, Moony A, Oliveira-dos-Santos G, Van A, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323.
24. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senalddi G, Guo J, Delaney J, Boyle WJ. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176.
25. Lark MW, Stroup GB, James IE, Dodds RA, Hwang SM, Blake SM, Lechowska BA, Huffman WF, Smith BR, Kapadia R, Liang K, Erhard K, Ru Y, Dong X, Marquis RW, Veber D, Gowen M. 2002. A potent small molecule, nonpeptide inhibitor of cathepsin K (SB331750) prevents bone matrix resorption in the ovariectomized rat. Bone 30:746-753.
26. +ATPase intracellularly and on their plasma membranes. Am J Physiol 39:C382-C388.
27. +ATPase and microfilaments during osteoclast activation. J Biol Chem 274:29164-29171.
28. Li J, Sarosi I, Yan XQ, Morony S, Capparelli C, Tan HL, McCabe S, Elliott R, Scully S, Van G, Kaufman S, Juan SC, Sun Y, Tarpley J, Martin L, Christensen K, McCabe J, Kostenuik P, Hsu H, Fretcher F, Dunstan CR, Lacey DL, Boyle WJ. 2000. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA 97:1566-1571.
29. Littlewood-Evans A, Kokubo T, Ishibashi O, Inaoka T, Wlodaski B, Gallagher JA, Bilbe G. 1997. Localization of cathepsin K in human osteoclasts by in situ hybridization and immunohistochemistry. Bone 20:81-86.
30. Matsuda E. 1992. Ultrastructural and cytochemical study of the odontoclasts in physiologic root resorption of human deciduous teeth. J Electron Microsc 41:131-140.
31. Matsuzaki K, Udagawa N, Takahashi N, Yamaguchi K, Yasuda H, Shima N, Morinaga T, Toyama Y, Yabe Y, Higashio K, Suda T. 1998. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Biochem Biophys Res Commun 246:199-204.
32. Mizuno A, Amizuka N, Irie K, Murakami A, Fujise N, Kanno T, Sato Y, Nakagawa N, Yasuda H, Mochizuki S, Gomibuchi T, Yano K, Shima N, Washida N, Tsuda E, Morinaga T, Higashio K, Ozawa H. 1998. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem Biophys Res Commun 247:610-615.
33. Murakami T, Yamamoto M, Ono K, Nishikawa M, Nagata N, Motoyoshi K, Akatsu T. 1998. Transforming growth factor-β1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells. Biochem Biophys Res Commun 252:747-752.
34. Nakamura I, Gailit J, Sasaki T. 1996. Osteoclast integrin αvβ3 is present in the clear zone and contributes to cellular polarization. Cell Tissue Res 286:507-515.
35. Nakamura I, Takahashi N, Udagawa N, Moriyama Y, Kurokawa T, Jimi E, Sasaki T, Suda T. 1997. Lack of vacuolar proton ATPase associated with the cytoskeleton in osteoclasts of osteosclerotic (oc/oc) mice. FEBS Lett 401:207-212.
36. O'Brien EA, Williams JHH, Marshall MJ. 2001. Osteoprotegerin is produced when prostaglandin synthesis is inhibited causing osteoclasts to detach from the surface of mouse parietal bone and attach to the endocranial membrane. Bone 28:208-214.
37. OkadaY, Naka K, Kawamura K, Matsumoto T, Nakanishi I, Fujimoto N, Sato H, Seiki M. 1995. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase=gelatinase B) in osteoclasts: Implications for bone resorption. Lab Invest 72:311-322.
38. +-ATPase, cathepsin K, matrix metalloproteinase-9, and receptor activator of NFkB Ligand in odontoclasts during physiological root resorption of human deciduous teeth. Anat Rec 264:305-311.
39. Oshiro T, Shiotani A, Shibasaki Y, Sasaki T. 2002. Osteoclast induction in periodontal tissue during experimental movement of incisors in osteoprotegerin-deficient mice. Anat Rec 266:218-225.
40. Palokangas H, Mulari M, Väänänen HK. 1997. Endocytic pathway from the basal membrane to the ruffled border membrane in bone-resorbing osteoclasts. J Cell Sci 110:1767-1780.
41. Reponen P, Sahlberg C, Munaut C, Thesleff I, Tryggvason K. 1994. High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J Cell Biol 124:1091-1102.
42. Rousselle AV, Heymann D. 2002. Osteoclastic acidification pathways during bone resorption. Bone 30:533-540.
43. Saftig P, Hunziker E, Wehmeyer O, Jones S, Boyde A, Rommerskirch W, Moritz JD, Schu P, von Figura K. 1998. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci USA 95:13453-13458.
44. Sahara N. 1998. Resorption and repair of human deciduous teeth prior to shedding. In: Davidovitch Z, Mah J, editors. Biological mechanisms of tooth eruption, resorption and replacement by implants. Birmingham: EBSCO Media. p 383-396.
45. Sahara N, Toyoki A, Ashizawa Y, Deguchi T, Suzuki K. 1994. Cytodifferentiation of the odontoclast prior to the shedding of human deciduous teeth. Anat Rec 244:33-49.
46. Sahara N, Okafuji N, Toyoki A, Ashizawa Y, Deguchi T, Suzuki K. 1996. Odontoclast resorption of superficial nonmineralized layer. Cell Tissue Res 277:19-26.
47. Sahara T, Sasaki T. 2001. Effects of Brefeldin-A: potent inhibitor of intracellular protein transport on ultrastructure and resorptive function of cultured osteoclasts. Anat Rec 263:127-138.
48. Sasaki T. 1996. Recent advances in the ultrastructural assessment of osteoclastic resorptive functions. Microsc Res Tech 33:182-191.
49. Sasaki T, Ueno-Matsuda E. 1992. Immunocytochemical localization of cathepsins B and G in odontoclasts of human deciduous teeth. J Dent Res 71:1881-1884.
50. Sasaki T, Motegi N, Suzuki H, Watanabe C, Tadokoro K, Yanagisawa T, Higashi S. 1988a. Dentin resorption mediated by odontoclasts in physiologic root resorption of human deciduous teeth. Am J Anat 183:303-315.
51. Sasaki T, Takahashi N, Watanabe C, Suzuki H, Higashi S, Suda T. 1988b. Cytodifferentiation of odontoclasts in physiologic root resorption of human deciduous teeth. In: Davidovitch Z, editor. Biological mechanisms of tooth eruption and root resorption. Birmingham: EBSCO Media. p 321-328.
52. Sasaki T, Shimizu T, Watanabe C, Hiyoshi Y. 1990. Cellular roles in physiological root resorption of deciduous teeth in the cat. J Dent Res 69:67-74.
53. +-ATPase in osteoclasts and its role in resorption. Cell Tissue Res 278:265-271.
54. Sato Y, Shibasaki Y, Sasaki T. 2000a. Effects of bisphosphonate administration on root and bone resorption during experimental movement of rat molars. In: Davidovitch Z, Mah J, editors. Biological mechanisms of tooth movement and craniofacial adaptation. Birmingham: EBSCO Media. p 243-252.
55. +-ATPase and cathepsin K in osteoclasts during experimental movement of rat molars. Anat Rec 260:72-80.
56. Scimeca JC, Franchi A, Trojani C, Parrinello H, Grosgeorge J, Robert C, Jaillon O, Poirier C, Gaudray P, Varle GF. 2000. The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants. Bone 26:207-213.
57. Shimizu-Ishiura T, Kawana F, Sasaki T. 2002. Osteoprotegerin administration reduces femoral bone loss in ovariectomized mice via impairment of osteoclast structure and function. J Electron Microsc 51:315-325.
58. Shiotani A, Shibasaki Y, Sasaki T. 2001. Localization of receptor activator of NFKB ligand, RANKL, in periodontal tissues during experimental movement of rat molars. J Electron Microsc 50:365-369.
59. Shiotani A, Takami M, Itoh K, Shibasaki Y, Sasaki T. 2002. Regulation of osteoclast differentiation and function by receptor activator of NFKB ligand and osteoprotegerin. Anat Rec, 268:137-146.
60. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Amgen EST Program, Boyle WJ. 1997. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309-319.
61. Sundquist K, Lakkakorpi P, Wallmark B, Väänänen K. 1990. Inhibition of osteoclast proton transport by bafilomycin A1 abolishes bone resorption. Biochem Biophys Res Commun 168:309-313.
62. Takami M, Woo JT, Nagai K. 1999. Osteoblastic cells induce fusion and activation of osteoclasts through a mechanism independent of macrophage-colony-stimulating factor production. Cell Tissue Res 298:327-334.
63. Tanaka T, Morioka N, Ayasaka N, Iijima T, Kondo T. 1990. Endocytosis in odontoclasts and osteoclasts using microperoxidase as a tracer. J Dent Res 69:883-889.
64. Thompson SK, Halbert SM, Bossard MJ, Tomaszek TA, Levy MA, Zhao B, Smith WW, Abdel-Meguid SS, Janson CA, D'Alessio KJ, McQueney MS, Amegadzie BY, Hanning CR, DesJarlais RL, Briand J, Sarkar SJ, Huddleston MJ, Ijames CF, Carr SA, Garnes KT, Shu A, Heys JR, Bradbeer J, Zembryki D, Lee-Tykaczewski L, James IE, Lark MW, Drake FH, Gowen M, Gleason JG, Veber DF. 1997. Design of potent and selective human cathepsin K inhibitors that span the active site. Proc Natl Acad Sci USA 94:14249-14254.
65. Tsuda E, Goto M, Mochizuki S, Yano K, Kobayashi F, Morinaga T, Higashio K. 1997. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 234:137-142.
66. 2, or parathyroid hormone in the microenvironment of bone. Biochem Biophys Res Commun 246:337-341.
67. Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T. 1999. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor. Bone 25:517-523.
68. Udagawa N, Takahashi N, Yasuda H, Mizuno A, Itoh K, Ueno Y, Shinki T, Gillespie MT, Martin TJ, Higashio K, Suda T. 2000. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology 141:3478-3484.
69. +-ATPase type in the ruffled borders of osteoclasts. J Cell Biol 111:1305-1311.
70. +-ATPase prevents bone loss in both thyroparathyroidectomized and ovariectomized rats. J Clin Invest 106:309-318.
71. Votta BJ, Levy MA, Bradger A, Bradbeer J, Dodds RA, James IE, Thompson S, Bossard MJ, Carr T, Connor JR, Tomaszek TA, Azewczuk L, Drake FH, Veber DF, Gowen M. 1997. Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivo. J Bone Miner Res 12:1396-1406.
72. Wucherpfennig AL, Li YP, Stetler-Stevenson WG, Rosenberg AE, Stashenko P. 1994. Expression of 92 kD type IV collagenase/gelatinase B in human osteoclasts. J Bone Miner Res 9:549-556.
73. Yano K, Tsuda E, Washida N, Kobayashi F, Goto M, Harada A, Ikeda K, Higashio K, Yamada Y. 1999. Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis. J Bone Miner Res 14:518-527.
74. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda A, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T. 1998a. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602.
75. Yasuda H, Shima N, Nakagawa N, Mochizuki S, Yano K, Fujise N, Sato Y, Goto M, Yamaguchi K, Kuriyama M, Kanno T, Murakami A, Tsuda E, Morinaga T, Higashio K. 1998b. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139:1329-1337.
76. Yazawa T, Goto T, Kamiya T, Kobayashi Y, Sakai H, Tanaka T. 1998. Study of immunoelectron microscopic localization of cathepsin K in osteoclasts and other bone cells in the mouse femur. Bone 23:499-509.
77. + -ATPase. J Dent Res 76:580-587.
78. Zeidel ML, Silva P, Seifter JL. 1986. Intracellular pH regulation and proton transport by rabbit renal medullary collecting duct cells. J Clin Invest 77:113-120.